Format

Send to

Choose Destination
Epilepsia. 2019 Jan;60(1):155-164. doi: 10.1111/epi.14618. Epub 2018 Dec 7.

Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability.

Author information

1
Department of Residential Care, Epilepsy Center Kempenhaeghe, Heeze, The Netherlands.
2
Academic Center for Epileptology Kempenhaeghe/Maastricht University Medical Center, Heeze, The Netherlands.
3
Department of Human Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
4
Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
5
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
6
Academic Center for Epileptology Kempenhaeghe/Maastricht University Medical Center, Maastricht, The Netherlands.
7
School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands.

Abstract

OBJECTIVE:

Epilepsy is highly prevalent among patients with intellectual disability (ID), and seizure control is often difficult. Identification of the underlying etiology in this patient group is important for daily clinical care. We assessed the diagnostic yield of whole exome sequencing (WES). In addition, we evaluated which clinical characteristics influence the likelihood of identifying a genetic cause and we assessed the potential impact of the genetic diagnosis on (antiepileptic) treatment strategy.

METHODS:

One hundred patients with both unexplained epilepsy and (borderline) ID (intelligence quotient ≤ 85) were included. All patients were evaluated by a clinical geneticist, a (pediatric) neurologist, and/or a specialist ID physician. WES analysis was performed in two steps. In step 1, analysis was restricted to the latest versions of ID and/or epilepsy gene panels. In step 2, exome analysis was extended to all genes (so-called full exome analysis). The results were classified according to the American College of Medical Genetics and Genomics guidelines.

RESULTS:

In 58 patients, the diagnostic WES analysis reported one or more variant(s). In 25 of the 100 patients, these were classified as (likely) pathogenic, in 24 patients as variants of uncertain significance, and in the remaining patients the variant was most likely not related to the phenotype. In 10 of 25 patients (40%) with a (likely) pathogenic variant, the genetic diagnosis might have an impact on the treatment strategy in the future.

SIGNIFICANCE:

This study illustrates the clinical diagnostic relevance of WES for patients with both epilepsy and ID. It also demonstrates that implementing WES diagnostics might have impact on the (antiepileptic) treatment strategy in this population. Confirmation of variants of uncertain significance in (candidate) genes may further increase the yield.

KEYWORDS:

genetic diagnosis; learning disability; next generation sequencing; seizures

PMID:
30525188
DOI:
10.1111/epi.14618

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center